Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha lipoic acid for assisted reproductive therapy outcomes in PCOS
IRCT20200905048630N4Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of alpha-lipoic acid in polycystic ovary syndrome (PCOS), sponsored by Hormozgan University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20200905048630N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200905048630N4.